Dr. Janina Schwenty Lara
About Dr. Janina Schwenty Lara
Dr. Janina Schwenty Lara serves as the Head of Manufacturing at Octapharma Plasma, Inc. in Gießen, Germany, and has held various roles within the company since 2021, including Quality Assurance and Deputy Responsible for Medical Device Safety.
Work at Octapharma Plasma
Dr. Janina Schwenty Lara has been employed at Octapharma Plasma, Inc. since 2021. She holds multiple roles within the organization, including Leiter der Herstellung and Quality Assurance. Her responsibilities in these positions involve overseeing manufacturing processes and ensuring compliance with quality standards. Additionally, she serves as Stv. Beauftragte für Medizinproduktesicherheit, focusing on medical device safety. Dr. Schwenty Lara's work is based in Gießen and Kassel, Hessen, Deutschland, where she has contributed to the company's operations for three years.
Education and Expertise
Dr. Janina Schwenty Lara earned her PhD in Molecular Embryology from Philipps-Universität Marburg, graduating summa cum laude in 2020. Her academic journey included a postdoctoral position at the same university, where she worked as a Research Scientist for four months in 2020. This educational background has equipped her with specialized knowledge and skills relevant to her current roles in the biopharmaceutical industry.
Background
Dr. Janina Schwenty Lara has a strong academic foundation in molecular biology, particularly in the field of embryology. Her experience as a PhD student at Philipps-Universität Marburg spanned six years, during which she developed expertise in research methodologies and scientific analysis. Following her doctoral studies, she transitioned into industry roles, applying her research skills to practical applications in biopharmaceutical manufacturing and quality assurance.
Professional Experience
Before joining Octapharma Plasma, Inc., Dr. Janina Schwenty Lara worked at Philipps-Universität Marburg as a Postdoctoral Research Scientist for a brief period in 2020. Her role involved advanced research projects that contributed to her professional development. This experience, combined with her extensive academic training, has positioned her well for her current responsibilities in the biopharmaceutical sector.